U.S. Markets close in 2 hrs 9 mins

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
35.93+0.48 (+1.35%)
As of 1:51PM EDT. Market open.
People also watch
MRKJNJJPMINTCGE
Full screen
Previous Close35.45
Open35.93
Bid35.90 x 7000
Ask35.91 x 5300
Day's Range35.82 - 36.21
52 Week Range29.83 - 36.21
Volume12,825,481
Avg. Volume17,372,446
Market Cap213.69B
Beta1.06
PE Ratio (TTM)26.28
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.28 (3.62%)
Ex-Dividend Date2017-08-02
1y Target EstN/A
Trade prices are not sourced from all markets
  • Market Realist3 minutes ago

    Behind Pfizer’s Product Developments after 2Q17

    On September 1, 2017, the FDA approved Pfizer's drug Mylotarg (gemtuzumab ozogamicin) for the treatment of CD33-positive acute myeloid leukemia.

  • The Wall Street Journal7 minutes ago

    [$$] Murky World of Drug Rebates Gets Airing in Lawsuit

    The closely guarded world of drug pricing is getting a public airing in a feud between two of the industry’s biggest companies. The attention drawn to rebates could hurt the profits of some very successful ...

  • Barrons.com12 minutes ago

    Pfizer: Is It Time To Buy?

    Shares of Pfizer (PFE) have made quite a run in recent weeks. Morgan Stanley’s David Risinger says the drug’s giant’s stock should keep rising, perhaps as high as $44 a share. Earlier today, Risinger upgraded Pfizer from an Equal-weight to an Outperform and set a $39 price target, which is based on a price-to-earnings multiple of 14 times 2018 estimated earnings of $2.76 a share.